Phio Pharmaceuticals Corp. (PHIO) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $50K. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | BRADFORD PATRICIA A Director | +$12,360 | 12,000 | +26% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Carson Lisa Cabott Chief Financial Officer | $13,275 | 12,888 | −14% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Bitterman Robert J Chairman, Pres. & CEO | $70,607 | 68,550 | −16% | No | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 19, 2026 | Plott Ronald Todd Director | +$17,100 | 15,000 | New | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 18, 2026 | Bitterman Robert J Chairman, Pres. & CEO | +$10,600 | 10,000 | +2% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free